Your Next Pain Prescription Could Come without Addiction Risk

The Food and Drug Administration has granted priority review to
suzetrigine, a novel painkiller. It’s part of a new class of
medications that could provide relief to those with chronic pain.
The drugs target sodium channels on nerve cells, stopping pain
signaling at the periphery. Journalist Marla Broadfoot explains the
biology of aches and pains and the reasons it is so challenging to
develop well-tolerated medications for pain. Recommended reading:
New Painkiller Could Bring Relief to Millions—Without Addiction
Risk  Ozempic Quiets Food Noise in the Brain—But How? 
E-mail us at sciencequickly@sciam.com if you have any questions,
comments or ideas for stories we should cover! Discover something
new every day: subscribe to Scientific American and sign up for
Today in Science, our daily newsletter.  Science Quickly is
produced by Rachel Feltman, Fonda Mwangi, Kelso Harper, Madison
Goldberg and Jeff DelViscio. This episode was hosted by Rachel
Feltman with guest Marla Broadfoot. Shayna Posses and Aaron
Shattuck fact-check our show. The theme music was composed by
Dominic Smith. Learn more about your ad choices. Visit
megaphone.fm/adchoices